| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $52.2M | +30.1% |
| SG&A Expense | $19.0M | -16.0% |
| Operating Income | -$73.6M | -17.4% |
| Pre-tax Income | -$65.4M | -66.3% |
| Net Income | -$65.4M | -66.3% |
| EPS (Basic) | -$3.11 | -35.8% |
| EPS (Diluted) | -$3.11 | -35.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.7M | -89.5% |
| Short-term Investments | $40.8M | — |
| Current Assets | $56.0M | -50.0% |
| Total Assets | $59.3M | -49.6% |
| Current Liabilities | $9.2M | -34.2% |
| Total Liabilities | $11.6M | -33.1% |
| Stockholders' Equity | $47.7M | -52.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.6M | -78.4% |
| Investing Cash Flow | -$40.6M | -671.7% |
| Financing Cash Flow | $280K | -99.7% |